Evidence map›Paper›PMID 38036687›Full record

ArticleEuropean journal of hybrid imaging2023

Signet cell rectal carcinoma with prostatic involvement detected by FAPI-04 PET-MRI fusion.

K Arun Prashanth, Deepti Jain, R Manikandan, Suman Kalyan, Vimalraj Velayutham, R Surendran

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hybrid imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K Arun PrashanthDepartment of Nuclear Medicine, MIOT International Hospital, Chennai, India. dr.arunprashanth@gmail.com.ORCID http://orcid.org/0000-0002-5588-7257
Deepti JainDepartment of Lab Services, MIOT International Hospital, Chennai, India.
R ManikandanDepartment of Urology, MIOT International Hospital, Chennai, India.
Suman KalyanDepartment of Medical Oncology, MIOT International Hospital, Chennai, India.
Vimalraj VelayuthamDepartment of Hepato-Pancreato-Biliary Centre for Surgery and Transplantation, MIOT International Hospital, Chennai, India.
R SurendranDepartment of Hepato-Pancreato-Biliary Centre for Surgery and Transplantation, MIOT International Hospital, Chennai, India.
Madras Institute of Orthopaedics and Traumatology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 60-year-old male patient diagnosed with mucinous adenocarcinoma of lower third of rectum underwent abdominoperineal resection and permanent colostomy followed by adjuvant chemotherapy. Response evaluation with F-18 FDG PET-CT showed a complete metabolic response. After 6 months, CEA levels started increasing and clinically a recurrence was suspected. A restaging FDG PET-CT showed no obvious malignant disease. Patient presented again within a month with complaints of urinary retention and haematuria. CEA levels were further elevated, and Ga-68 FAPI-04 (FAPI) PET-CT was performed. FAPI PET-CT revealed prostatic and seminal vesicle disease involvement. Additionally, an MRI of pelvis was done and fused with FAPI PET for confirmation of prostatic involvement.

Indexed as

FAPIFAPI MRI fusionFibroblast activation protein inhibitor PET-CTProstate secondariesRectal adenocarcinomaSignet cell adenocarcinoma

Identifiers

PMID38036687
PMCPMC10689635
OpenAlexW4389209274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.